Jishi Wang

Jishi Wang

Auto-generated profile, based on publicly available information

Jishi Wang

Laboratory of Hematopoietic Stem Cell Transplantation Centre of Guizhou Province, Guiyang, Guizhou, China; Department of Haematology, Affiliated Hospital of Guizhou Medical University, Guizhou, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Transplant Immunology
Verified
Journal Article
Closed access
MYMeisheng Yu
Meisheng Yu
JWJishi Wang
Jishi Wang
QFQin Fang
Qin Fang
PLPing Liu
Ping Liu
SCShuya Chen
Shuya Chen
ZZZhen Zhou
Zhen Zhou

9 September 2016 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
YLYing-Hao Lu
Ying-Hao Lu
DWDepei Wu
Depei Wu
JWJishi Wang
Jishi Wang
YLYan Li
Yan Li
DMDan Ma
Dan Ma
QKQian Kang
Qian Kang
Objective: The main aim of this study was to determine the correlation between clinical outcome and heme oxygenase-1 (HO-1) expression before and after hematopoietic stem cell transplantation (HSCT) in acute leukemia. Methods: HO-1 mRNA levels in 83 patients were measured using qRT-PCR. In a comparative analysis of HO-1 levels in relation to different post-transplant outcomes, the HO-1 threshold, determined via the receiver operating characteristic (ROC) curve, was effectively used to predict clinical relapse and acute graft-versus-host disease (aGVHD). The correlations among clinical relapse, aGVHD and HO-1 expression were analyzed based on this threshold. Results: Leukemia risk stratification and relative expression of HO-1 before pretreatment had significant effects on clinical relapse. Leukemia risk stratification, relative expression of HO-1 after HSCT and the interval from diagnosis to transplantation had a significant influence on aGVHD. Both relapse and aGVHD appeared to be associated with relative HO-1 expression. The relative expression rate of HO-1 was 1.131-1.186 before pretreatment, and strongly associated with post-transplantation relapse. The relative expression rate of HO-1 was 1.102-1.144 after transplantation, and closely related to aGVHD. ROC curve analysis revealed high specificity and sensitivity of HO-1 expression in predicting relapse and aGVHD after allo-HSCT. Conclusions: HO-1 expression can be effectively used as a predictor of relapse as well as a diagnostic factor of aGVHD after transplantation for allo-HSCT patients with acute leukemia.

1 February 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SZSi-Yu Zhang
Si-Yu Zhang
CPChengyun Pan
Chengyun Pan
QSQin Shang
Qin Shang
WWWeili Wang
Weili Wang
THTianzhen Hu
Tianzhen Hu
QFQin Fang
Qin Fang